Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Is the EQ-5D suitable for use in oncology? An overview of literature and recent developments.

Schwenkglenks M, Matter-Walstra K.

Expert Rev Pharmacoecon Outcomes Res. 2016 Jan 25. [Epub ahead of print]

PMID:
26808097
2.

Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.

Matter-Walstra K, Braun R, Kolb C, Ademi Z, Dummer R, Pestalozzi BC, Schwenkglenks M.

Br J Dermatol. 2016 Jan 20. doi: 10.1111/bjd.14279. [Epub ahead of print] No abstract available.

PMID:
26787297
3.

Planning and reporting of quality-of-life outcomes in cancer trials.

Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group.

Ann Oncol. 2016 Jan;27(1):209. doi: 10.1093/annonc/mdv559. Epub 2015 Nov 25. No abstract available.

PMID:
26612098
4.

Using lung cancer mortality to indirectly approximate smoking patterns in space.

Jürgens V, Ess S, Schwenkglenks M, Cerny T, Vounatsou P.

Spat Spatiotemporal Epidemiol. 2015 Jul-Oct;14-15:23-31. doi: 10.1016/j.sste.2015.06.003. Epub 2015 Jul 13.

PMID:
26530820
5.

Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study.

Schandelmaier S, von Elm E, You JJ, Blümle A, Tomonaga Y, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Cook DJ, Meade MO, Bucher HC, Kasenda B, Briel M.

Crit Care Med. 2016 Jan;44(1):130-7. doi: 10.1097/CCM.0000000000001369.

PMID:
26468895
6.

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland.

Gutzwiller FS, Pfeil AM, Ademi Z, Blank PR, Braunhofer PG, Szucs TD, Schwenkglenks M.

Pharmacoeconomics. 2015 Dec;33(12):1311-24. doi: 10.1007/s40273-015-0320-9.

7.

A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting.

Matter-Walstra K, Braun R, Kolb C, Ademi Z, Dummer R, Pestalozzi BC, Schwenkglenks M.

Br J Dermatol. 2015 Dec;173(6):1462-70. doi: 10.1111/bjd.14152. Epub 2015 Nov 7.

PMID:
26332527
8.

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.

Vulsteke C, Pfeil AM, Maggen C, Schwenkglenks M, Pettengell R, Szucs TD, Lambrechts D, Dieudonné AS, Hatse S, Neven P, Paridaens R, Wildiers H.

Breast Cancer Res Treat. 2015 Jul;152(1):67-76. doi: 10.1007/s10549-015-3437-9. Epub 2015 May 28.

PMID:
26017071
9.

Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.

Pfeil AM, Reich O, Guerra IM, Cure S, Negro F, Müllhaupt B, Lavanchy D, Schwenkglenks M.

PLoS One. 2015 May 14;10(5):e0126984. doi: 10.1371/journal.pone.0126984. eCollection 2015.

10.

Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma.

Jakovljevic M, Gutzwiller F, Schwenkglenks M, Milovanovic O, Rancic N, Varjacic M, Stojadinovic D, Dagovic A, Matter-Walstra K.

J BUON. 2014 Oct-Dec;19(4):1111-20.

PMID:
25536624
11.

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

Blank PR, Filipits M, Dubsky P, Gutzwiller F, Lux MP, Brase JC, Weber KE, Rudas M, Greil R, Loibl S, Szucs TD, Kronenwett R, Schwenkglenks M, Gnant M.

Pharmacoeconomics. 2015 Feb;33(2):179-90. doi: 10.1007/s40273-014-0227-x.

12.

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.

Huber CA, Diem P, Schwenkglenks M, Rapold R, Reich O.

Diabetes Metab Syndr Obes. 2014 Oct 1;7:455-65. doi: 10.2147/DMSO.S69520. eCollection 2014.

13.

Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.

Pfeil AM, Allcott K, Pettengell R, von Minckwitz G, Schwenkglenks M, Szabo Z.

Support Care Cancer. 2015 Feb;23(2):525-45. doi: 10.1007/s00520-014-2457-z. Epub 2014 Oct 7. Review.

PMID:
25284721
14.

Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89/09.

Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Jundt G, Konzelmann I, Clough-Gorr K, Szucs T, Pestalozzi BC, Schwenkglenks M.

Oncology. 2015;88(1):18-27. doi: 10.1159/000367629. Epub 2014 Sep 26.

PMID:
25277324
15.

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).

Pfeil AM, Imfeld P, Pettengell R, Jick SS, Szucs TD, Meier CR, Schwenkglenks M.

Ann Hematol. 2015 Mar;94(3):421-9. doi: 10.1007/s00277-014-2217-7. Epub 2014 Sep 16.

PMID:
25219890
16.

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.

Vulsteke C, Pfeil AM, Schwenkglenks M, Pettengell R, Szucs TD, Lambrechts D, Peeters M, van Dam P, Dieudonné AS, Hatse S, Neven P, Paridaens R, Wildiers H.

Breast Cancer Res Treat. 2014 Oct;147(3):557-70. doi: 10.1007/s10549-014-3105-5. Epub 2014 Aug 29.

PMID:
25168315
17.

Impact of Body Mass Index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist?

Witassek F, Schwenkglenks M, Erne P, Radovanovic D.

Swiss Med Wkly. 2014 Aug 7;144:w13986. doi: 10.4414/smw.2014.13986. eCollection 2014.

18.

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M; DISCO Study Group.

BMJ. 2014 Jul 16;349:g4539. doi: 10.1136/bmj.g4539. Erratum in: BMJ. 2014;349:4921. Kasenda, Benjamin [added]; Schandelmaier, Stefan [added]; Sun, Xin [added]; von Elm, Erik [added]; You, John [added]; Blümle, Anette [added]; Tomonaga, Yuki (8) Saccilotto, Ramon (9) Amstutz, Alain [added]; Bengough, Theresa [added]; etc..

19.

PAIN OUT: an international acute pain registry supporting clinicians in decision making and in quality improvement activities.

Zaslansky R, Rothaug J, Chapman RC, Backström R, Brill S, Engel C, Fletcher D, Fodor L, Funk P, Gordon D, Komann M, Konrad C, Kopf A, Leykin Y, Pogatzki-Zahn E, Puig M, Rawal N, Schwenkglenks M, Taylor RS, Ullrich K, Volk T, Yahiaoui-Doktor M, Meissner W.

J Eval Clin Pract. 2014 Dec;20(6):1090-8. doi: 10.1111/jep.12205. Epub 2014 Jul 1.

PMID:
24986116
20.

Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study.

Rosenthal R, Kasenda B, Dell-Kuster S, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

Ann Surg. 2015 Jul;262(1):68-73. doi: 10.1097/SLA.0000000000000810.

PMID:
24979608
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk